AVIDITY BIOSCIENCES, INC.
Clinical trial NCT07038200: enrollment: not set → 200 participants.
SHANGHAI HENLIUS BIOTECH INC. (SGBCF)
Clinical trial NCT06115642 updates: 1. status: RECRUITING → ENROLLING_BY_INVITATION 2. enrollment: not set → 367 participants
BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT05296096 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-06-30 → 2026-01-01 3. enrollment: not set → 18 participants
AGIOS PHARMACEUTICALS, INC. (AGIO)
Clinical trial NCT05490446: enrollment: not set → 87 participants.
MERCK & CO., INC. (MRK)
Clinical trial NCT06430801: enrollment: not set → 1200 participants.
ABBVIE INC. (ABBV)
Clinical trial NCT07024784: enrollment: not set → 377 participants.
REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07430956: enrollment: not set → 2628 participants.
MERCK & CO., INC. (MRK)
Clinical trial NCT05418790 updates: 1. status: UNKNOWN → WITHDRAWN 2. start date: 2022-07-01 → 2022-06-01 3. completion date: 2023-09-01 → 2022-06-02 4. primary completion date: 2023-08-01 → 2022-06-02
ULTRAGENYX PHARMACEUTICAL INC. (RARE)
Clinical trial NCT06636383: enrollment: not set → 140 participants.
SANOFI (SNYNF)
Clinical trial NCT03774914 updates: 1. status: TERMINATED → COMPLETED 2. enrollment: not set → 42 participants